Endogenous DNA damage and TP53 mutation profiles in human cancers

被引：0
|
作者：
Hainaut, P [1 ]
机构：
[1] Int Agcy Res Canc, F-69372 Lyon, France
来源：
TOXICOLOGY AND APPLIED PHARMACOLOGY | 2004年 / 197卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
66
引用
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [21] TP53 mutation, mitochondria and cancer
    Kamp, William M.
    Wang, Ping-yuan
    Hwang, Paul M.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2016, 38 : 16 - 22
  • [22] TP53 Mutation in Waldenstrom Macroglobulinemia
    Poulain, Stephanie
    Roumier, Christophe
    Bertrand, Elisabeth
    Renneville, Aline
    Tricot, Sabine
    Venet, Aurelie Caillault
    Geffroy, Sandrine
    Nudel, Morgan
    Herbaux, Charles
    Guidez, Stephanie
    Preudhomme, Claude
    Leleu, Xavier
    BLOOD, 2016, 128 (22)
  • [23] TP53 mutation in colorectal cancer
    Iacopetta, B
    HUMAN MUTATION, 2003, 21 (03) : 271 - 276
  • [24] Polymorphisms in XPD and TP53 and mutation in human lung cancer
    Mechanic, LE
    Marrogi, AJ
    Welsh, JA
    Bowman, ED
    Khan, MA
    Enewold, L
    Zheng, YL
    Chanock, S
    Shields, PG
    Harris, CC
    CARCINOGENESIS, 2005, 26 (03) : 597 - 604
  • [25] TP53 mutation in ovarian carcinoma
    Murphy, M
    McManus, DT
    Toner, PG
    Russell, SEH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1281 - 1283
  • [26] On the complexity measures of mutation hotspots in human TP53 protein
    Ding, Yan
    Xue, Hongsheng
    Ding, Xinjia
    Zhao, Yuqing
    Zhao, Zhilong
    Wang, Dazhi
    Wu, Jianlin
    CHAOS, 2020, 30 (07)
  • [27] The Response to DNA Damage in CLL Cells Is Partly Determined by the Type of TP53 Mutation and Genomic Aberrations
    Mohr, Julia
    Zenz, Thorsten
    Winkler, Dirk
    Buehler, Andreas
    Mertens, Daniel
    Doehner, Hartmut
    Stilgenbauer, Stephan
    BLOOD, 2008, 112 (11) : 1069 - 1070
  • [28] DNA-based biosensor platforms for the detection of TP53 mutation
    Altintas, Z.
    Tothill, I. E.
    SENSORS AND ACTUATORS B-CHEMICAL, 2012, 169 : 188 - 194
  • [29] TP53 as a biomarker of cytogenetic damage
    Hendrikse, A
    Hunter, A
    Blekkenhorst, G
    HEALTH PHYSICS, 2000, 78 (06): : 753 - 753
  • [30] TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
    Olivier, Magali
    Hollstein, Monica
    Hainaut, Pierre
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (01): : a001008
12345